MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.3861 -0.0438 (-10.19%)
Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,467,437
Open 0.4210
Bid (Size) 0.3815 (1,700)
Ask (Size) 0.3892 (600)
Prev. Close 0.4299
Today's Range 0.3640 - 0.4210
52wk Range 0.1616 - 1.320
Shares Outstanding 34,919,920
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion
More than 15 proprietary brands and product lines, plus 10 branded generics - across nutraceuticals, infection control, advanced formulations, skin care and mother & baby, and branded generics... 
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue
Record Q2 2026 revenue of over $15 million , an annualized run-rate of over $60 million, at wholly owned subsidiary CosmoFarm Revenue up 4.3x under Cosmos Health ownership - from ~$14 million in fiscal... 
From Cosmos Health Inc.
Via ACCESS Newswire

Performance

YTD
-25.0%
-25.0%
1 Month
+69.4%
+69.4%
3 Month
+62.8%
+62.8%
6 Month
+25.8%
+25.8%
1 Year
-64.9%
-64.9%

More News

Read More
News headline image
Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market
From Cosmos Health Inc.
Via ACCESS Newswire
News headline image
Cosmos Health: A Company Transformed — 2026 Year-to-Date
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Launches Subscription Model
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases
From Cosmos Health Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Cosmos Health Inc. - Common Stock publicly traded?
Yes, Cosmos Health Inc. - Common Stock is publicly traded.
What exchange does Cosmos Health Inc. - Common Stock trade on?
Cosmos Health Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cosmos Health Inc. - Common Stock?
The ticker symbol for Cosmos Health Inc. - Common Stock is COSM on the Nasdaq Stock Market
What is the current price of Cosmos Health Inc. - Common Stock?
The current price of Cosmos Health Inc. - Common Stock is 0.3861
When was Cosmos Health Inc. - Common Stock last traded?
The last trade of Cosmos Health Inc. - Common Stock was at 10/01/26 04:00 PM ET
What is the market capitalization of Cosmos Health Inc. - Common Stock?
The market capitalization of Cosmos Health Inc. - Common Stock is 13.48M
How many shares of Cosmos Health Inc. - Common Stock are outstanding?
Cosmos Health Inc. - Common Stock has 13M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story